• Our Financial News
  • Ad Hoc Announcements from Medios AG

AD-HOC

  • March 18, 2024
  • 20:41

Medios acquires Dutch market leader in pharmaceutical compounding services

AD-HOC

  • November 22, 2022
  • 13:06

Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing

AD-HOC

  • March 03, 2022
  • 12:05

Medios AG exceeds revenue and EBT pre1 forecasts for financial year 2021 - Executive Board optimistic for financial year 2022

AD-HOC

  • December 03, 2021
  • 08:01

Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option

AD-HOC

  • December 02, 2021
  • 17:40

Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital

AD-HOC

  • November 25, 2021
  • 12:14

Medios acquires NewCo Pharma Group

AD-HOC

  • November 26, 2020
  • 18:30

Medios AG acquires Cranach Pharma GmbH; issue of 4,180,000 new Medios shares; significant increase in sales expected in 2021 to over €1 billion

AD-HOC

  • October 21, 2020
  • 18:12

Medios AG: Chief Executive Officer Manfred Schneider resigns from the Company's Executive Board as scheduled - Chief Financial Officer Matthias Gärtner to become the new Chief Executive Officer with early extension of his term of office

AD-HOC

  • August 05, 2020
  • 11:42

Medios AG adjusts forecast for 2020 financial year downward

AD-HOC

  • June 04, 2020
  • 08:04

Medios AG successfully completes capital increase with gross proceeds of approximately €53m